These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 18580387)

  • 21. Somnolence effects of antipsychotic medications and the risk of unintentional injury.
    Said Q; Gutterman EM; Kim MS; Firth SD; Whitehead R; Brixner D
    Pharmacoepidemiol Drug Saf; 2008 Apr; 17(4):354-64. PubMed ID: 18314925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polypharmacy with second-generation antipsychotics: a review of evidence.
    Pandurangi AK; Dalkilic A
    J Psychiatr Pract; 2008 Nov; 14(6):345-67. PubMed ID: 19057237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Words matter: increasing the implementation of clinical guidelines.
    Michie S; Lester K
    Qual Saf Health Care; 2005 Oct; 14(5):367-70. PubMed ID: 16195572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticholinergic use in hospitalised schizophrenic patients in Belgium.
    De Hert M; Wampers M; van Winkel R; Peuskens J
    Psychiatry Res; 2007 Aug; 152(2-3):165-72. PubMed ID: 17445906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and effectiveness of first- and second-generation antipsychotics in schizophrenia.
    Jaffe AB; Levine J
    J Clin Psychiatry; 2003; 64 Suppl 17():3-6. PubMed ID: 14680419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety monitoring of patients on atypical antipsychotics.
    Peh AL
    Qual Saf Health Care; 2008 Dec; 17(6):469-72. PubMed ID: 19064665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of monitoring and management guidelines for second-generation antipsychotics.
    Sernyak MJ
    J Clin Psychiatry; 2007; 68 Suppl 4():14-8. PubMed ID: 17539695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
    Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
    Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological management of acute mania: does current prescribing practice reflect treatment guidelines?
    Streeruwitz A; Barnes TR; Fehler J; Ohlsen R; Curtis VA
    J Psychopharmacol; 2007 Mar; 21(2):206-9. PubMed ID: 17329301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The DEBIT trial: an intervention to reduce antipsychotic polypharmacy prescribing in adult psychiatry wards - a cluster randomized controlled trial.
    Thompson A; Sullivan SA; Barley M; Strange SO; Moore L; Rogers P; Sipos A; Harrison G
    Psychol Med; 2008 May; 38(5):705-15. PubMed ID: 17825122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative evaluation of clinical practice guidelines for the treatment of schizophrenia].
    Delessert D; Pomini V; Grasset F; Baumann P
    Encephale; 2008 Jan; 34(1):93-100. PubMed ID: 18514156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients.
    Morrato EH; Cuffel B; Newcomer JW; Lombardo I; Kamat S; Barron J
    J Clin Psychopharmacol; 2009 Feb; 29(1):26-32. PubMed ID: 19142103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guideline adherence in medication management of psychotic disorders: an observational multisite hospital study.
    Weinmann S; Janssen B; Gaebel W
    Acta Psychiatr Scand; 2005 Jul; 112(1):18-25. PubMed ID: 15952941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving adherence to guidelines for hypertension drug prescribing: cluster-randomized controlled trial of general versus patient-specific recommendations.
    Goldstein MK; Lavori P; Coleman R; Advani A; Hoffman BB
    Am J Manag Care; 2005 Nov; 11(11):677-85. PubMed ID: 16268751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Explicit versus implicit review to explore combination antipsychotic prescribing.
    Wheeler A
    J Eval Clin Pract; 2009 Aug; 15(4):685-91. PubMed ID: 19674220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementing effectiveness research and improving care for schizophrenia in real-world settings.
    Buckley PF; Miller A; Chiles JA; Sajatovic M
    Am J Manag Care; 1999 Jun; 5 Spec No():SP47-56. PubMed ID: 10538860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline.
    Peters-Klimm F; Müller-Tasch T; Remppis A; Szecsenyi J; Schellberg D
    J Eval Clin Pract; 2008 Oct; 14(5):823-9. PubMed ID: 19018915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Switching antipsychotics in inpatient schizophrenia care: predictors and outcomes.
    Weinmann S; Janssen B; Gaebel W
    J Clin Psychiatry; 2004 Aug; 65(8):1099-105. PubMed ID: 15323596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined treatment with amisulpride in patients with schizophrenia discharged from a short-term hospitalization unit: a 1-year retrospective study.
    Molina JD; Lerma-Carrillo I; Leonor M; Pascual F; Blasco-Fontecilla H; González-Parra S; López-Muñoz F; Alamo C
    Clin Neuropharmacol; 2009; 32(1):10-5. PubMed ID: 18978498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.